Bolt Biotherapeutics Inc

General ticker "BOLT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $21.8M

Bolt Biotherapeutics Inc does not follow the US Stock Market performance with the rate: -39.1%.

Estimated limits based on current volatility of 3.7%: low 0.48$, high 0.52$

Factors to consider:

  • Current price 27.5% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.71$, 1.91$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.98$, 2.43$]

Financial Metrics affecting the BOLT estimates:

  • Negative: Non-GAAP EPS, $ of -1.83 <= 0.10
  • Negative: Operating profit margin, % of -90.63 <= 1.03
  • Negative: Operating cash flow per share per price, % of -65.74 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term BOLT quotes

Long-term BOLT plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.26MM $5.73MM $7.88MM
Operating Expenses $94.05MM $96.05MM $84.07MM
Operating Income $-92.79MM $-90.32MM $-76.20MM
Non-Operating Income $-5.80MM $2.22MM $7.00MM
R&D Expense $75.66MM $73.12MM $61.54MM
Income(Loss) $-98.59MM $-88.10MM $-69.20MM
Profit(Loss) $-98.59MM $-88.10MM $-69.20MM
Stockholders Equity $250.12MM $171.51MM $112.74MM
Inventory $0.20MM $0.80MM $0.00MM
Assets $307.72MM $227.81MM $159.78MM
Operating Cash Flow $-57.07MM $-76.50MM $-69.53MM
Capital expenditure $2.34MM $1.95MM $0.21MM
Investing Cash Flow $-232.20MM $57.86MM $71.04MM
Financing Cash Flow $311.11MM $0.50MM $0.25MM
Earnings Per Share* $-2.79 $-2.30 $-1.83

* EPS are Split Adjusted, recent splits may be reflected with a delay.